Eric Venker, President & COO at Roivant Sciences Ltd. (ROIV), sold 139,148 shares at $10.95 ($1.5M) on 2025-05-20, disclosed to the SEC on 2025-05-22.
Scheduled sale ($1.5M) by President & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.95 | 100,000 | $1.1M | 71.7% |
| 2 | $11.04 | 39,148 | $432K | 28.3% |
| Total | $10.98 avg | 139,148 | $1.5M | 100% |
| Filing → |
| ROIV | SELL | 2026-09-01 | $7.2M | — | Filing → |
| ROIV | SELL | 2026-07-29 | $7.0M | — | Filing → |
| IMVT | SELL | 2026-07-06 | $119K | — | Filing → |